Parallel to fingerprinting of leukemia subclasses by gene expression profiling we propose to fingerprint leukemia subclasses using protein expression data collected by quantitative flow cytometry. A number of acute lymphoblastic leukemia subclasses with characteristic chromosomal aberrations (MLL; Bcr/Abl;E2A/PBX;TEL/AML1;hyperdiploid) have a unique gene expression profile as demonstrated by microarray studies (1-2). Among genes differentially expressed between leukemia subtypes are known proteins of which expression can be measured by quantitative flow cytometry using monoclonal antibodies (3). Here, univariate t-tests and multivariate principal component analysis (PCA) have been applied to profile phenotypes of 145 pB-ALL samples using...
The general aim of this thesis was to characterize hematologic malignancies using gene expression pr...
Pediatric acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy, and the second...
Background Classification of cancer subtypes by means of microarray signatures is becoming increasin...
Parallel to fingerprinting of leukemia subclasses by gene expression profiling we propose to fingerp...
Precursor B-acute lymphoblastic leukemia (pB-ALL) is a heterogeneous disease and multiparameter flow...
Precursor B-acute lymphoblastic leukemia (pB-ALL) is a heterogeneous disease and multiparameter flow...
Improved leukemia classification and tailoring of therapy have greatly improved patient outcome part...
Acute leukemia, defined as a genetic disease, is the most common cancer in children representing abo...
AbstractTreatment of pediatric acute lymphoblastic leukemia (ALL) is based on the concept of tailori...
Improved leukemia classification and tailoring of therapy have greatly improved patient outcome part...
Purpose The Microarray Innovations in Leukemia study assessed the clinical utility of gene expressio...
Background Pediatric acute myeloid leukemia is a heterogeneous disease characterized by non-random g...
We determined the genome-wide digital gene expression (DGE) profiles of primary acute lymphoblastic ...
The uncontrolled proliferation of hematopoietic cells with no capacity to differentiate into mature ...
Pediatric acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy, and the second...
The general aim of this thesis was to characterize hematologic malignancies using gene expression pr...
Pediatric acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy, and the second...
Background Classification of cancer subtypes by means of microarray signatures is becoming increasin...
Parallel to fingerprinting of leukemia subclasses by gene expression profiling we propose to fingerp...
Precursor B-acute lymphoblastic leukemia (pB-ALL) is a heterogeneous disease and multiparameter flow...
Precursor B-acute lymphoblastic leukemia (pB-ALL) is a heterogeneous disease and multiparameter flow...
Improved leukemia classification and tailoring of therapy have greatly improved patient outcome part...
Acute leukemia, defined as a genetic disease, is the most common cancer in children representing abo...
AbstractTreatment of pediatric acute lymphoblastic leukemia (ALL) is based on the concept of tailori...
Improved leukemia classification and tailoring of therapy have greatly improved patient outcome part...
Purpose The Microarray Innovations in Leukemia study assessed the clinical utility of gene expressio...
Background Pediatric acute myeloid leukemia is a heterogeneous disease characterized by non-random g...
We determined the genome-wide digital gene expression (DGE) profiles of primary acute lymphoblastic ...
The uncontrolled proliferation of hematopoietic cells with no capacity to differentiate into mature ...
Pediatric acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy, and the second...
The general aim of this thesis was to characterize hematologic malignancies using gene expression pr...
Pediatric acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy, and the second...
Background Classification of cancer subtypes by means of microarray signatures is becoming increasin...